BIT 0.00% 3.2¢ biotron limited

Award winning BIT, page-2

  1. 67 Posts.
    lightbulb Created with Sketch. 5

    Dr Carolyn Luscombe, Head of Research and Development, has received an award at the HIV DART and Emerging Viruses 2018 in Miami, Florida for the presentation entitled“BIT225-009: Significant Immunological Outcomes after 12 weeks of BIT225 and Antiretroviral Therapy in an HIV-1 Phase 2 Clinical Trial”.

    The award is an acknowledgement of the importance of the outcomes from the Phase 2 trial data presented, as well as the robustness of the science underlying the Company’s programs. 

    Thank you for your interest in Biotron.

    Regards Michelle

    Dr Michelle Miller | CEO & Managing Director | Biotron Limited



 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $17.40K 542.8K

Buyers (Bids)

No. Vol. Price($)
1 17000 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 120000 2
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.